芳香酶抑制剂相关的骨骼和肌肉骨骼影响：新的证据定义病因和管理策略。
Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management.
机构信息
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, 1650 Orleans Street, CRBI, Room 144, Baltimore, MD 21231, USA.
出版信息
Breast Cancer Res. 2011 Mar 14;13(2):205. doi: 10.1186/bcr2818.
Abstract
Aromatase inhibitors are widely used as adjuvant therapy in postmenopausal women with hormone receptor-positive breast cancer. While the agents are associated with slightly improved survival outcomes when compared to tamoxifen alone, bone and musculoskeletal side effects are substantial and often lead to discontinuation of therapy. Ideally, the symptoms should be prevented or adequately treated. This review will focus on bone and musculoskeletal side effects of aromatase inhibitors, including osteoporosis, fractures, and arthralgias. Recent advances have been made in identifying potential mechanisms underlying these effects. Adequate management of symptoms may enhance patient adherence to therapy, thereby improving breast cancer-related outcomes.
摘要
芳香酶抑制剂被广泛用作激素受体阳性乳腺癌绝经后妇女的辅助治疗。与单独使用他莫昔芬相比，这些药物的生存获益略有改善，但与骨骼和肌肉骨骼相关的副作用显著，且常导致治疗中断。理想情况下，应预防或充分治疗这些症状。本文将重点讨论芳香酶抑制剂的骨骼和肌肉骨骼副作用，包括骨质疏松症、骨折和关节痛。目前已在确定这些作用的潜在机制方面取得了一些进展。充分管理症状可能会提高患者对治疗的依从性，从而改善乳腺癌相关结局。
相似文献
1
Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management.芳香酶抑制剂相关的骨骼和肌肉骨骼影响：新的证据定义病因和管理策略。
Breast Cancer Res. 2011 Mar 14;13(2):205. doi: 10.1186/bcr2818.
2
Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management.芳香化酶抑制剂相关的肌肉骨骼症状：病因及管理策略
Oncology (Williston Park). 2008 Nov 15;22(12):1401-8.
3
Aromatase inhibitor-associated arthralgia syndrome.芳香化酶抑制剂相关关节痛综合征
Breast. 2007 Jun;16(3):223-34. doi: 10.1016/j.breast.2007.01.011. Epub 2007 Mar 21.
4
5
[Treatment with Aromatase Inhibitors in Postmenopausal Women with Breast Cancer and the Possibility of Influencing Side Effects].[芳香化酶抑制剂治疗绝经后乳腺癌妇女及影响副作用的可能性]
Klin Onkol. 2016 Fall;29 Suppl 3:S39-49. doi: 10.14735/amko20163S39.
6
Aromatase inhibitors and arthralgia: a growing pain?
Oncology (Williston Park). 2008 Nov 15;22(12):1424, 1426.
7
Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women.绝经后女性乳腺癌辅助治疗中芳香化酶抑制剂相关副作用的发生率及管理
Curr Med Res Opin. 2006 Aug;22(8):1609-21. doi: 10.1185/030079906X115667.
8
Toxicity of aromatase inhibitors.
Semin Oncol. 2006 Dec;33(6):688-95. doi: 10.1053/j.seminoncol.2006.08.011.
9
Improving tolerance of AIs: predicting risk and uncovering mechanisms of musculoskeletal toxicity.
Oncology (Williston Park). 2008 Nov 15;22(12):1416, 1424.
10
The effects of adjuvant endocrine therapy on bone health in women with breast cancer.辅助内分泌治疗对乳腺癌女性骨骼健康的影响。
J Endocrinol. 2019 Jun 1;241(3):R111-R124. doi: 10.1530/JOE-19-0077.
引用本文的文献
1
Aromatase Inhibitor-Induced Carpal Tunnel Syndrome Immunohistochemical Analysis and Clinical Evaluation: An Observational, Cross-Sectional, Case-Control Study.芳香化酶抑制剂诱发的腕管综合征：免疫组织化学分析与临床评估：一项观察性、横断面、病例对照研究
J Clin Med. 2025 Aug 5;14(15):5513. doi: 10.3390/jcm14155513.
2
Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Breast Cancer.大麻二酚治疗乳腺癌中芳香化酶抑制剂相关肌肉骨骼症状的初步研究。
Cancer Med. 2025 Aug;14(15):e71117. doi: 10.1002/cam4.71117.
3
Expanding Horizons of Buprenorphine: A Comprehensive Narrative Review of Its Pharmacological Properties and Clinical Applications in Chronic Pain.丁丙诺啡的拓展视野：关于其药理特性及在慢性疼痛中临床应用的全面叙述性综述
Pain Ther. 2025 Jun 22. doi: 10.1007/s40122-025-00753-3.
4
Deciphering the anti-neoplastic potential of Allium ascalonicum in averting the proliferation and epithelial-mesenchymal transition of triple-negative breast cancer through virtual docking and In Vitro approaches.通过虚拟对接和体外实验方法解读葱在抑制三阴性乳腺癌增殖和上皮-间质转化方面的抗肿瘤潜力。
BMC Cancer. 2025 Mar 7;25(1):414. doi: 10.1186/s12885-025-13796-8.
5
Risk factors for and incidence of osteoporosis in patients with breast cancer by gender : a nationwide cohort study.按性别划分的乳腺癌患者骨质疏松症的危险因素及发病率：一项全国性队列研究
Sci Rep. 2025 Feb 5;15(1):4413. doi: 10.1038/s41598-025-89059-0.
6
Efficacy of a single 5 mg zoledronic acid infusion in preventing bone loss and fracture in postmenopausal women with breast cancer.单次静脉输注5毫克唑来膦酸对预防绝经后乳腺癌女性骨质流失和骨折的疗效。
J Bone Miner Metab. 2024 Nov;42(6):720-727. doi: 10.1007/s00774-024-01552-0. Epub 2024 Sep 30.
7
The role of exercise in aromatase inhibitor-induced arthralgia.运动在芳香化酶抑制剂所致关节痛中的作用。
PM R. 2024 Dec;16(12):1406-1416. doi: 10.1002/pmrj.13193. Epub 2024 May 23.
8
Pain associated with breast cancer: etiologies and therapies.与乳腺癌相关的疼痛：病因与治疗
Front Pain Res (Lausanne). 2023 Dec 11;4:1182488. doi: 10.3389/fpain.2023.1182488. eCollection 2023.
9
Total Hip Arthroplasty With Prophylactic Fixation of Greater Trochanter and Distal Femur in a Patient With a History of Multiple Myeloma and Breast Cancer.对一名有多发性骨髓瘤和乳腺癌病史的患者行全髋关节置换术并预防性固定大转子和股骨远端
Cureus. 2023 Apr 22;15(4):e37971. doi: 10.7759/cureus.37971. eCollection 2023 Apr.
10
Kinin B and B Receptors Activation Sensitize the TRPA1 Channel Contributing to Anastrozole-Induced Pain Symptoms.激肽B及B受体激活使TRPA1通道敏感化，导致阿那曲唑诱导的疼痛症状。
Pharmaceutics. 2023 Apr 3;15(4):1136. doi: 10.3390/pharmaceutics15041136.
本文引用的文献
1
Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study.维生素 D 阈值预防芳香化酶抑制剂引起的关节痛：一项前瞻性队列研究。
Breast Cancer Res Treat. 2011 Feb;125(3):869-78. doi: 10.1007/s10549-010-1075-9. Epub 2010 Jul 28.
2
American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.美国临床肿瘤学会临床实践指南：激素受体阳性乳腺癌患者辅助内分泌治疗的更新。
J Clin Oncol. 2010 Aug 10;28(23):3784-96. doi: 10.1200/JCO.2009.26.3756. Epub 2010 Jul 12.
3
Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women.抑制卵泡刺激素分泌对绝经后妇女骨吸收标志物的影响。
J Clin Endocrinol Metab. 2010 Nov;95(11):5063-8. doi: 10.1210/jc.2010-1103. Epub 2010 Jul 7.
4
Cancer statistics, 2010.癌症统计数据，2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
5
Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study.炎症细胞因子与芳香化酶抑制剂相关的肌肉骨骼综合征：病例对照研究。
Br J Cancer. 2010 Jul 27;103(3):291-6. doi: 10.1038/sj.bjc.6605768. Epub 2010 Jul 6.
6
A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography.一项关于芳香酶抑制剂相关的肌肉骨骼症状和连续高分辨率腕关节超声异常的前瞻性研究。
Cancer. 2010 Sep 15;116(18):4360-7. doi: 10.1002/cncr.25385.
7
Menopausal arthralgia: Fact or fiction.更年期关节痛：事实还是虚构？
Maturitas. 2010 Sep;67(1):29-33. doi: 10.1016/j.maturitas.2010.04.009.
8
Combining Src inhibitors and aromatase inhibitors: a novel strategy for overcoming endocrine resistance and bone loss.联合Src 抑制剂和芳香酶抑制剂：克服内分泌耐药和骨质丢失的新策略。
Eur J Cancer. 2010 Aug;46(12):2187-95. doi: 10.1016/j.ejca.2010.04.012. Epub 2010 May 13.
9
Regulation of adult bone turnover by sex steroids.性激素对成骨转换的调节作用。
J Cell Physiol. 2010 Aug;224(2):305-10. doi: 10.1002/jcp.22159.
10
New views on treatment of aromatase inhibitors induced arthralgia.关于治疗芳香化酶抑制剂引起的关节痛的新观点。
Breast. 2010 Jun;19(3):249-50. doi: 10.1016/j.breast.2010.03.031. Epub 2010 Apr 24.
Zotero 插件